Risk of mortality by histologic type of breast cancer in the United States

Hormones and Cancer

Volumn 1, Issue 3, 2010, Pages 156-165

  Li, Christopher I ^a  

^a USA   (United States)

Author keywords

Breast cancer; Ductal carcinoma; Histology; Lobular carcinoma; Mortality

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 77955559694     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0016-8     Document Type: Article

References (15)

1. Li CI, Daling JR (2007) Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev 16(12): 2773-2780.
2. Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9): 1046-1052.
3. Li CI, Moe RE, Daling JR (2003) Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 163(18): 2149-2153.
4. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc (B) 34: 187-220.
5. Rakha EA, Lee AH, Evans AJ et al (2009) Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 28(1): 99-104.
6. Louwman MW, Vriezen M, van Beek MW et al (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121(1): 127-135.
7. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97(13): 966-975.
8. Dian D, Herold H, Mylonas I et al (2009) Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet 279(1): 23-28.
9. Allemani C, Sant M, Berrino F et al (2004) Prognostic value of morphology and hormone receptor status in breast cancer-a population-based study. Br J Cancer 91(7): 1263-1268.
10. Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y (2004) Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 90(6): 1138-1143.
11. Viale G, Rotmensz N, Maisonneuve P et al (2009) Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 117(1): 211-214.
12. Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6(3): R149-R156.
13. Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26(18): 3006-3014.
14. Davis RP, Nora PF, Kooy RG, Hines JR (1979) Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. Arch Surg 114(4): 485-488.
15. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW (1982) Infiltrating lobular carcinoma of the breast. Histopathology 6(2): 149-161.